SCG Cell Therapy, a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and th...
Researchers from the Yong Loo Lin School of Medicine (NUS Medicine) in Singapore have developed a groundbreaking way to ...
The Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine), Kailuan General Hospital, Ti...
Global health disparities have been identified as one of the most severe public health threats of the century, which pla...
The global bioeconomy is on the brink of a transformation as sweeping as the rise of AI, with bioengineering breakthroug...
myTomorrows, a global health technology company connecting patients with all possible treatment options, announced its e...
Royal Philips, a global leader in health technology, announces its strategic collaboration with Singapore General H...
To recognise and celebrate the remarkable achievements and contributions of Asian companies and individuals in the life ...
The Singapore University of Social Sciences (SUSS) has launched the Intercontinental Alliance for Integrated Care (IAIC)...
In October 2023, Johnson & Johnson announced a collaboration with the Singapore Economic Development Board (EDB) to ...
Climate change poses a direct and urgent threat to the health of patients and the viability of health systems in Asia, a...
Singapore Minister for Health Ong Ye Kung and the Kingdom of Saudi Arabia Minister of Health Fahad bin Abdurrahman Al-Ja...
Sanofi announced the inauguration of its state-of-theart manufacturing facility, Modulus, in Singapore, on 27 Nov, marki...
Royal Philips, a global leader in health technology, has released the second set of Asia Pacific (APAC) findin...
The Cardiovascular Disease National Collaborative Enterprise (CADENCE) and Medera Inc. (“Merdera”)’s S...
Sanofi, the Agency for Science, Technology and Research (A*STAR), and the National Skin Centre Singapore (NSC) establish...
The National University Health System (NUHS) and Sahlgrenska University Hospital have formed a strategic partnership wit...
Roche Pharmaceuticals has shared encouraging 16-week interim data from its ongoing phase 3b/4 SALWEEN trial, showing sig...
